High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions.

BACKGROUND To measure HIV-1 RNA concentration requires venous extraction of blood, use of RNAase-free materials, and transport in a cold chain, which makes difficult the management of samples in developing countries. We evaluated the utility of the determination of HIV-1 RNA concentration in blood samples dried on filter paper (DBS) and subjected to different conditions, as contrasted with determination in plasma. METHODS HIV-1 RNA concentration was determined in HIV-infected patients in DBS and in plasma samples. Samples were subjected to the following: DBS were stored at 4, 22, and 37 degrees C for 1, 3, and 7 days; samples from patients from four regions of Mexico were mailed to a reference laboratory; DBS were sent under environmental conditions; and plasma samples were sent frozen. HIV-1 RNA concentrations were determined by NucliSens in DBS and by Amplicor test in plasma. RESULTS HIV-1 RNA concentration determined in DBS subjected to different temperatures and times had a significant correlation (r=0.99) with those obtained in plasma. When compared with values in plasma, Kappa agreement coefficients of values in DBS stored for 7 days at 4, 22, and 37 degrees C were 0.98, 0.83, and 0.94, respectively. Quantification of HIV-1 RNA in 108 DBS mailed from remote areas with different climates demonstrated significant correlation with those obtained in plasma (r=0.95; p <0.001). CONCLUSIONS DBS is a simple and reliable method to measure HIV-1 RNA concentration, especially when samples are mailed from remote areas to a reference center. This collection method is an economic and suitable alternative for use in developing countries.

[1]  S. Cummings,et al.  Designing Clinical Research: An Epidemiologic Approach , 1988 .

[2]  T. Quinn,et al.  Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome , 1998, Journal of Clinical Microbiology.

[3]  J. Overbaugh,et al.  Rapid Method for Screening Dried Blood Samples on Filter Paper for Human Immunodeficiency Virus Type 1 DNA , 1999, Journal of Clinical Microbiology.

[4]  M. Salminen,et al.  Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. , 1996, AIDS research and human retroviruses.

[5]  Michael R. Glass,et al.  Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. , 1996, Biochemical and molecular medicine.

[6]  N. Lapointe,et al.  Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1 , 1994, Journal of clinical microbiology.

[7]  J V Mei,et al.  Use of filter paper for the collection and analysis of human whole blood specimens. , 2001, The Journal of nutrition.

[8]  M. V. Sydow,et al.  Filter paper sampling of blood infected with HIV: effect of heat on antibody activity and viral infectivity. , 1988, BMJ.

[9]  L. Portney,et al.  Foundations of Clinical Research , 1993 .

[10]  Alimuddin Zumla,et al.  Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients , 2003, The Lancet.

[11]  Alimuddin Zumla,et al.  Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients , 2003, The Lancet.

[12]  M. Gill,et al.  Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper , 1997, Journal of clinical microbiology.

[13]  G. Aldrovandi,et al.  Multicenter Evaluation of Use of Dried Blood and Plasma Spot Specimens in Quantitative Assays for Human Immunodeficiency Virus RNA: Measurement, Precision, and RNA Stability , 2003, Journal of Clinical Microbiology.

[14]  J. Seigneurin,et al.  The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals. , 1991, Journal of virological methods.

[15]  Tom Lang,et al.  How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers , 1997 .

[16]  G. Hammersen,et al.  Neonatal Screening for Inborn Errors of Metabolism , 1980, Springer Berlin Heidelberg.

[17]  H. Karlsson,et al.  Extraction of RNA from dried blood on filter papers after long-term storage. , 2003, Clinical chemistry.

[18]  M. Rigsby,et al.  Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles , 1997, Journal of clinical microbiology.

[19]  D. van Strijp,et al.  Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. , 1993, Journal of virological methods.

[20]  Christopher D. Pilcher,et al.  Comparison of NucliSens and Roche Monitor Assays for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1999, Journal of Clinical Microbiology.

[21]  S. Parker,et al.  The use of the dried blood spot sample in epidemiological studies. , 1999, Journal of clinical pathology.

[22]  R. Guthrie.  Organization of a Regional Newborn Screening Laboratory , 1980 .

[23]  D. Brambilla,et al.  Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma by Using Blood Dried on Filter Paper , 1998, Journal of Clinical Microbiology.

[24]  E. De Clercq,et al.  Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.